跳至主要内容
临床试验/NCT04936633
NCT04936633已完成不适用

Efficacy of Remote Intervention by Medical Staff Based on a Cloud System of Continuous Glucose Monitoring Data in Patients With Insulin-dependent Diabetes Using a Flash Sensor-based Glucose Monitoring (FSGM)

Young Shin Song2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2021年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
2
主要终点
Changes in glycemic control measured by HbA1c

研究概览

简要总结

To investigate the efficacy of remote intervention by medical staff based on a cloud system of continuous glucose monitoring data in patients with insulin-dependent diabetes using flash sensor-based glucose monitoring (FSGM).

详细描述

  • Previous studies have been reported on the efficacy of CGM or FSGM and education on glucose control in insulin-dependent diabetes patients.
  • This study aims to investigate whether it is more effective to receive remote intervention by medical staff based on a cloud system, than only to use FSGM and receive general education on FSGM.
  • Trial design : parallel group, allocation ratio 1:1, a superiority study design

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women aged 19 to 75 years old
  • Patients with type 1 diabetes
  • Patients on multiple daily insulin-injection or continuous subcutaneous insulin infusion therapy for more than 1 year
  • Patients with HbA1c ≥ 7.0% at screening
  • Patients willing to use a FSGM system
  • Patients with informed consent

排除标准

  • Gestational diabetes patients
  • Patients within 1 year of diabetic diagnosis
  • Patients taking drugs for severe cognitive impairment or psychiatric problems
  • Patients who received oral or parenteral corticosteroid therapy for more than 7 consecutive days within 1 month before screening test
  • Patients with severe infection, before and after surgery, and severe trauma
  • Patients on dialysis at the end of renal failure
  • Patients who have a history of substance abuse or alcoholism within 12 weeks through patient history taking, diagnosis records, and past treatment records
  • Pregnant or lactating women
  • Participating in other clinical trials under R&D other than this clinical trial, or if other clinical trial drugs are administered within 4 weeks before the trial
  • Patients who are using a CGMS/FSGM or who have been using it within 12 weeks

结局指标

主要结局

Changes in glycemic control measured by HbA1c

时间窗: 3 months

Difference between baseline HbA1c and follow-up HbA1c

次要结局

  • Changes in the mean glucose values(3 months)
  • Changes in hypoglycemic episodes(3 months)
  • Changes in the patient relative satisfaction with treatment assessed by questionnaires(3 months)
  • Changes in depression assessed by questionnaires(3 months)
  • Changes in the duration of hypoglycemic episodes(3 months)
  • Changes in the duration of hyperglycemic episodes(3 months)
  • Changes in blood pressure(3 months)
  • Changes in body weight(3 months)
  • Lifestyle changes in the duration of exercises(3 months)
  • Changes in the time in range(3 months)
  • Changes in the mean number of scans(3 months)
  • Changes in the frequency of use of trend arrows(3 months)
  • Changes in the insulin dose(3 months)
  • Changes in the lipid parameter(3 months)
  • Lifestyle changes in diet(3 months)
  • Lifestyle changes in the number of exercises(3 months)
  • Changes in the patient absolute satisfaction with treatment assessed by questionnaires(3 months)
  • Changes in anxiety assessed by questionnaires(3 months)

研究者

发起方
Young Shin Song
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Young Shin Song

A ssistant Professor

CHA University

研究点 (2)

Loading locations...

相似试验